Compliance and Regulatory Statement
Clinical Governance & Regulatory Framework
Nūūtro operates within a clinical governance and regulatory framework under which all peptides and related compounds are provided strictly for research and educational purposes only.
1. Legal Status of Compounds
In the United Kingdom, many advanced peptide compounds are classified as unlicensed products.
Statutory Compliance: We operate strictly within the framework of the Human Medicines Regulations 2012.
Research Justification: These compounds are only discussed where a client’s specific research needs cannot be met by an equivalent licensed alternative.
Non-Commercial Provision: We do not maintain a “shop” or “pharmacy” for public purchase. All compounds are made available solely as part of a bespoke, individually tailored research plan.
2. Advertising and Public Communication
Nūūtro adheres to the UK Code of Non-broadcast Advertising and Direct & Promotional Marketing (CAP Code) and the Human Medicines Regulations 2012.
Prohibition of Public Promotion: We do not advertise unlicensed compounds to the general public.
Educational Intent: Information provided on this website is intended for scientific literacy and educational awareness. It does not constitute a recommendation for any specific compound.
Factual Accuracy: All claims are based on emerging peer-reviewed literature and are qualified as “investigational” or “research-led” where appropriate.
3. Safety and Monitoring
Client welfare is the cornerstone of our model. We maintain a high-integrity safety framework for every individual under our care.
Diagnostic Integrity: No research plan is initiated without a comprehensive evaluation and a review of medical history.
Informed Consent: We ensure clients receive clear, jargon-free disclosures regarding the nature of their research plan, particularly regarding the use of unlicensed products, before any plan begins.
Professional Disclaimer
The content provided by Nūūtro is for informational and educational purposes only and does not serve as a substitute for professional medical diagnosis or advice. We do not claim to “cure” or “treat” specific diseases through public-facing content. All medical decisions occur exclusively within the privacy of a formal consultation with your own registered healthcare professional.
By participating in our Peptide Programme with Nūūtro, you acknowledge the following:
1. Understanding “Unlicensed” Products
I understand that some of the peptides or compounds discussed by Nūūtro may be classified as unlicensed products in the United Kingdom. I acknowledge that while these substances are manufactured to Good Manufacturing Practice (GMP) standards, they may not hold a UK Marketing Authorisation for the specific application being discussed. I understand and have researched in-depth why an unlicensed product is appropriate for my individual research goals over a licensed alternative, and on this basis I am proceeding with the programme.
2. Research Rationale & Emerging Evidence
I understand that peptides are an emerging area of research within regenerative and longevity science. I have been informed that while there is peer-reviewed evidence supporting the biological mechanisms of these peptides, some applications are based on emerging research and observational experience rather than long-term, large-scale UK clinical trials. I acknowledge that results are individual and not guaranteed.
3. Risks, Side Effects, and Monitoring
I have been made aware of the potential risks and side effects associated with my specific programme, which may include but are not limited to: localised reactions (redness, bruising, or swelling at the injection site) and systemic effects (to be detailed by the Specialist during consultation).
Reporting: I agree to immediately notify the clinic of any adverse reactions. I understand that all adverse events are documented and reviewed by the Peptide Specialist as part of Nūūtro’s internal safety monitoring process.
4. Client Responsibilities
Accuracy: I confirm that I have provided a full and accurate medical history, including all current medications and supplements.
Administration: I agree to follow my recommended programme strictly as directed by the Specialist and will not alter the dosage or frequency without prior consultation.
Monitoring: I understand that ongoing monitoring is a mandatory requirement for continuing my programme.